Inovio Pharmaceuticals, Inc. (INO)
1.01
+0.01
(+1.00%)
USD |
NASDAQ |
Oct 20, 16:00
1.05
+0.04
(+3.96%)
After-Hours: 07:49
Inovio Pharmaceuticals Gross Profit (TTM) : -3.015M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.015M |
| March 31, 2026 | -2.991M |
| December 31, 2025 | -2.924M |
| September 30, 2025 | -2.828M |
| June 30, 2025 | -2.844M |
| March 31, 2025 | -2.831M |
| December 31, 2024 | -2.912M |
| September 30, 2024 | -2.326M |
| June 30, 2024 | -2.204M |
| March 31, 2024 | -2.394M |
| December 31, 2023 | -2.672M |
| September 30, 2023 | -3.823M |
| June 30, 2023 | 4.614M |
| March 31, 2023 | 4.906M |
| December 31, 2022 | 5.943M |
| September 30, 2022 | 6.627M |
| June 30, 2022 | -1.166M |
| March 31, 2022 | -0.5401M |
| December 31, 2021 | -0.5401M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Nektar Therapeutics | 53.90M |
| Ironwood Pharmaceuticals, Inc. | 387.48M |
| Fortress Biotech, Inc. | 40.31M |
| Tonix Pharmaceuticals Holding Corp. | 22.27M |
| Kura Oncology, Inc. | 75.37M |